PL1992362T3 - Sposoby wytwarzania zakonserwowanych kompozycji zawierających kwas hialuronowy lub jego farmaceutycznie dopuszczalną sól - Google Patents

Sposoby wytwarzania zakonserwowanych kompozycji zawierających kwas hialuronowy lub jego farmaceutycznie dopuszczalną sól

Info

Publication number
PL1992362T3
PL1992362T3 PL08251713T PL08251713T PL1992362T3 PL 1992362 T3 PL1992362 T3 PL 1992362T3 PL 08251713 T PL08251713 T PL 08251713T PL 08251713 T PL08251713 T PL 08251713T PL 1992362 T3 PL1992362 T3 PL 1992362T3
Authority
PL
Poland
Prior art keywords
pharmaceutically
methods
acceptable salt
hyaluronic acid
compositions containing
Prior art date
Application number
PL08251713T
Other languages
English (en)
Inventor
Uday Doshi
Kenneth T Holeva
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39534841&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1992362(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of PL1992362T3 publication Critical patent/PL1992362T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
PL08251713T 2007-05-16 2008-05-15 Sposoby wytwarzania zakonserwowanych kompozycji zawierających kwas hialuronowy lub jego farmaceutycznie dopuszczalną sól PL1992362T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/803,873 US8609634B2 (en) 2007-05-16 2007-05-16 Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
EP08251713A EP1992362B1 (en) 2007-05-16 2008-05-15 Methods for preparing preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof

Publications (1)

Publication Number Publication Date
PL1992362T3 true PL1992362T3 (pl) 2013-08-30

Family

ID=39534841

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08251713T PL1992362T3 (pl) 2007-05-16 2008-05-15 Sposoby wytwarzania zakonserwowanych kompozycji zawierających kwas hialuronowy lub jego farmaceutycznie dopuszczalną sól

Country Status (8)

Country Link
US (1) US8609634B2 (pl)
EP (3) EP2508205A3 (pl)
JP (2) JP5905196B2 (pl)
AU (1) AU2008254369B2 (pl)
CA (1) CA2687264C (pl)
ES (1) ES2402312T3 (pl)
PL (1) PL1992362T3 (pl)
WO (1) WO2008144185A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9579341B2 (en) 2007-05-16 2017-02-28 Johnson & Johnson Consumer Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US8609634B2 (en) * 2007-05-16 2013-12-17 Mcneil-Ppc, Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
BR112015018414B1 (pt) * 2013-02-01 2022-11-08 Allergan, Inc Lágrimas artificiais compreendendo hialuronato de sódio e carboximetilcelulose
ES2621877B1 (es) 2016-01-04 2018-05-04 Agencia Pública Empresarial Sanitaria Hospital De Poniente Solución para resección endoscópica
IE87094B1 (en) 2017-08-04 2020-05-13 Laboratorios Kin S A Gel comprising chlorhexidine
CN115120618B (zh) * 2021-03-23 2024-01-26 安徽盛美诺生物技术有限公司 具有改善免疫应答作用的软骨提取物、其制备方法及其用途

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT252264B (de) 1965-03-17 1967-02-10 Etapharm Chem Pharm Lab Ges M Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
JPS5318520B2 (pl) 1972-07-05 1978-06-15
AU499860B2 (en) 1975-04-24 1979-05-03 Honda Giken Kogyo Kabushiki Kaisha Deflector plate to equalise fuel distribution in induction gas flow
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4371522A (en) 1979-04-25 1983-02-01 Gilbard Jeffrey P Keratoconjunctivitis sicca therapy
US4443432A (en) 1981-10-05 1984-04-17 Alcon Laboratories, Inc. Ophthmalic irrigating solution
JPS5945890A (ja) 1982-09-09 1984-03-14 Toyo Jozo Co Ltd 新規抗生物質アクミマイシンおよびその製造法
US5316926A (en) 1983-11-25 1994-05-31 Miles Inc. Method for the microbiological production of non-antigenic hyaluronic acid
US5409904A (en) 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US5202431A (en) 1985-07-08 1993-04-13 Fidia, S.P.A. Partial esters of hyaluronic acid
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JPH075456B2 (ja) 1988-10-01 1995-01-25 参天製薬株式会社 点眼液
JP2536166B2 (ja) 1989-07-19 1996-09-18 富士電機株式会社 プリント板に実装した電子回路装置の供給装置
EP0464727B1 (en) 1990-06-29 1996-01-03 Santen Pharmaceutical Co., Ltd. Use of a composition for the preparation of a medicament for debridment of retained lens material
JP3050898B2 (ja) 1990-07-06 2000-06-12 千寿製薬株式会社 水性医薬製剤
US5492936A (en) 1990-11-30 1996-02-20 Allergan, Inc. Bimodal molecular weight hyaluronate formulations and methods for using same
JP3337218B2 (ja) 1992-05-06 2002-10-21 アルコン ラボラトリーズ，インコーポレイテッド 眼科用組成物におけるホウ酸塩−ポリオール複合体の使用
US5505953A (en) 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
SE9401806D0 (sv) 1994-05-26 1994-05-26 Pharmacia Ab Method and means for the production of hyaluronic acid
IT1273011B (it) 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
JPH09176020A (ja) 1995-12-28 1997-07-08 Takada Seiyaku Kk 安定なヒアルロン酸ナトリウム含有溶液
JPH1160505A (ja) 1997-05-20 1999-03-02 Senju Pharmaceut Co Ltd 防腐組成物
US7691829B2 (en) 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
JP2002020279A (ja) 2000-06-30 2002-01-23 Taisho Pharmaceut Co Ltd 点眼液
JP2002356420A (ja) 2001-03-27 2002-12-13 Santen Pharmaceut Co Ltd 安定な水性液剤
US20060094643A1 (en) 2002-07-03 2006-05-04 Yuri Svirkin Compositions of hyaluronic acid and methods of use
KR20050057251A (ko) 2002-09-09 2005-06-16 산텐 세이야꾸 가부시키가이샤 라타노프로스트를 유효 성분으로 하는 투명한 점안액
US20060251685A1 (en) * 2003-03-18 2006-11-09 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
US20050196370A1 (en) 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
JP3876232B2 (ja) 2003-04-18 2007-01-31 有限会社ユーワ商事 眼科用製剤、点眼液、人工涙液、コンタクトレンズケアー用品、洗眼液、および眼軟膏
PT1759702E (pt) 2004-05-26 2009-04-13 Arturo Jimenez Bayardo Método de preparação de uma solução oftálmica de latanoprost e a solução assim produzida
US8609634B2 (en) * 2007-05-16 2013-12-17 Mcneil-Ppc, Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods

Also Published As

Publication number Publication date
JP2010527363A (ja) 2010-08-12
WO2008144185A2 (en) 2008-11-27
US20080287672A1 (en) 2008-11-20
EP1992362A2 (en) 2008-11-19
EP1992362B1 (en) 2013-03-13
CA2687264C (en) 2016-07-05
ES2402312T3 (es) 2013-04-30
EP3006046A1 (en) 2016-04-13
US8609634B2 (en) 2013-12-17
JP5905196B2 (ja) 2016-04-20
EP1992362A3 (en) 2009-08-12
AU2008254369A1 (en) 2008-11-27
AU2008254369B2 (en) 2014-07-03
CA2687264A1 (en) 2008-11-27
JP5925823B2 (ja) 2016-05-25
WO2008144185A3 (en) 2009-09-03
JP2014101386A (ja) 2014-06-05
EP2508205A2 (en) 2012-10-10
EP2508205A3 (en) 2012-12-26

Similar Documents

Publication Publication Date Title
HUS1800016I1 (hu) Fungicid készítmények
TWI371277B (en) Salt form
IL205071A0 (en) Azolecarboxamide compound or salt thereof
EP2305641A4 (en) SULPHONAMIDE COMPOUND OR SALT THEREOF
IL209794A0 (en) Fungicidal compositions
GB0800760D0 (en) Fungicidal compositions
EP2133324A4 (en) INCLUSION HYDRATE WITH A QUATERNARY AMMONIA SALT AS ADDITIONAL COMPOUND
HK1132458A1 (en) Ophthalmic composition containing alginic acid or salt thereof
EP2249641A4 (en) NOVEL COMPOSITIONS CONTAINING XANTHOHUMOL / CYCLODEXTRIN COMPLEXES
GB0822837D0 (en) Fungicidal compositions
IL202301A0 (en) Tetrahydroisoquinolin-1-one derivative or salt thereof
GB0702382D0 (en) New salt
PL1992362T3 (pl) Sposoby wytwarzania zakonserwowanych kompozycji zawierających kwas hialuronowy lub jego farmaceutycznie dopuszczalną sól
ZA201100032B (en) Triazole derivative or salt thereof
EP2155759A4 (en) METHODS FOR THE PREPARATION OF DIORGANOZINC COMPOUNDS
HK1158031A1 (en) Low sodium salt substitute compositions
EP2567675A4 (en) BONE TRANSPLANTATION OR BONE FILLING COMPOSITION WITH A DIHYDROXYBENZOIC ACID DERIVATIVE
PL2187863T3 (pl) Przeciwpotowe sole okso-heksameryczny cyrkon-oktaaminokwasu
HK1157788A1 (en) Silylimidazolium salt complexes
GB0800840D0 (en) Novel salt
GB0806341D0 (en) Reduced sodium salt
GB0717513D0 (en) Salt counter
GB0804698D0 (en) Fungicidal compositions
IL206473A0 (en) Stable elsamitrucin salt formulations